Nasacort

This page contains recent news articles, when available, and an overview of Nasacort but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Overview:

Nasacort (when available)

Pharmacology and use:
Triamcinolone and its derivatives are synthetic glucocorticoids that are used for their antiinflammatory or immunosuppressive properties. For the treatment of perennial and seasonal allergic rhinitis

Mechanism Of Action:
The antiinflammatory actions of corticosteroids are thought to involve lipocortins, phospholipase A2 inhibitory proteins which, through inhibition of arachidonic acid, control the biosynthesis of prostaglandins and leukotrienes. The immune system is suppressed by corticosteroids due to a decrease in the function of the lymphatic system, a reduction in immunoglobulin and complement concentrations, the precipitation of lymphocytopenia, and interference with antigen-antibody binding.

News Articles on Triamcinolone

Watch the door, take the keys  -  ‎Aug 25, 2009‎
And as we reported in late July, Sanofi-aventis recently lost to thieves a trailer full of the blood thinner Lovenox, the antihistamines Xyzal and Nasacort FiercePharma Manufacturing

BRIEF: Teva, Perrigo get FDA nod for allergy nasal spray: Teva ...  -  ‎Aug 4, 2009‎
Brand Nasacort has annual US sales of $305 million, according to Wolters Kluwer data. Teva's share closed at $53.58 on Nasdaq yesterday, Trading Markets (press release)

Market Report / TA-25 down 0.4%, but vaccine shares jump  -  ‎Aug 4, 2009‎
Teva Pharmaceuticals received approval from the US Food and Drug Administration to sell its generic version of the Nasacort nasal spray for children's Ha'aretz

Perrigo Company F4Q09 (Qtr End 06/27/09) Earnings Call Transcript  -  ‎Aug 18, 2009‎
In November 2008 we acknowledged the settlement of patent litigation relating to generic Nasacort AQ, triamcinolone nasal spray products brought by Seeking Alpha

Markets in Brief  -  ‎Aug 4, 2009‎
The product is the AB-rated equivalent to Sanofi-Aventis' Nasacort, which is used to treat nasal allergy symptoms in adults and children. Ha'aretz

How to get the perfect UK summer holiday  -  ‎Aug 7, 2009‎
...copy of 'Healthy Holiday, Happy Family Guide' by writing to PO Box 4030, Worthing, West Sussex, BN11 1RZ or visiting nasacort.co.uk to download a copy. Easier (press release)

הירידות בבורסה התמתנו לקר�?ת הסגירה: המעו"ף �?יבד 0.4%  -  ‎Aug 4, 2009‎
...החברות ישווקו גרסה גנרית של תרופת ה-NASACORT, המיועדת לטיפול ב�?לרגיה במבוגרי�? וילדי�? מעל לגיל 6. היקף המכירות של התרופה נ�?מד ב-305 מיליון דולר. גלובס

שומרי�? על �?ופטימיות בוול סטריט: המסחר ננעל בעליות שערי�? קלות ...  -  ‎Aug 4, 2009‎
...טבע (0.22% , 53.7) קיבלה �?ישור מרשות המזון והתרופות ה�?מריק�?ית (FDA) לשווק גירסה גנרית ל-Nasacort ספריי במתן ב�?מצעות ה�?ף, לטיפול בסימפטומי�? של �?לרגיות וילדי�? The Marker

הבורסה נסגרה בירידות שערי�? קלות  -  ‎Aug 4, 2009‎
...על 5.5622 שקלי�? פריגו יורדת בכ-0.38% ל�?חר שהודיעה �?מש כי שותפתה, טבע, זכתה ל�?ישור לשיווק תרופה גנרית ממנהל התרופות והמזון ה�?מריקני העונה לש�? NASACORT. ynet ידיעות אחרונות

State DHS accepts settlement from Aventis Pharmaceuticals  -  ‎Jul 2, 2009‎
The settlement resolves allegations that the company knowingly misreported best prices for anti-inflammatory nasal sprays Azmacort, Nasacort, and Nasacort Jamestown Sun

Latest North Dakota news, sports, business and entertainment:...  -  ‎Jul 2, 2009‎
...between 1995 and 2000, Aventis and its corporate predecessors did not offer Medicaid the best prices for the sprays Azmacort, Nasacort and Nasacort AQ. Reiten Television KXMB Bismarck

BUYINS.NET: BLUD, NVO, RBN, ROS, SNY, CPII. Abnormal Price ...  -  ‎Jun 26, 2009‎
Acomplia, Taxotere, Eloxatine, Stilnox/Ambien/Myslee, Copaxone, Depakine, Allegra/Telfast, Nasacort, Xatral/Uroxatral, and Actonel/Optinate/Acrel. Trading Markets (press release)

SNY-A Sanofi Safety Scare?  -  ‎Jun 26, 2009‎
Acomplia, Taxotere, Eloxatine, Stilnox/Ambien/Myslee, Copaxone, Depakine, Allegra/Telfast, Nasacort, Xatral/Uroxatral, and Actonel/Optinate/Acrel. TransWorldNews (press release)

Pet Allergies  -  ‎Apr 16, 2009‎
For non-asthmatic symptoms (sneezing and watery eyes), pet lovers can use non-systemic medications such as Lanacort (a cream), Nasacort (an inhaler), Victorville Daily Press

Lessen your allergy impact this spring  -  ‎Apr 4, 2009‎
Corticosteroid nasal sprays, such as Flonase, Nasacort AQ, Rhinocort Aqua, Nasalide and Nasarel, Beconase AQ and Nasonex may help you breathe better and Daily Comet

Common drugs can help allergic rhinitis  -  ‎Mar 29, 2009‎
...to control sneezing, a runny nose and nasal congestion are corticosteroid nasal sprays such as Omnaris, Flonase, Nasacort AQ, Nasonex, and Rhinocort AQ. Daytona Beach News-Journal

GAZZETTA UFFICIALE: SOMMARIO (4)  -  18 Mar 2009
Variazione di tipo II, secondo procedura di mutuo riconoscimento, all'autorizzazione all'immissione in commercio del medicinale per uso umano "Nasacort". ANSA Valle d'Aosta

How to avoid spring allergies  -  ‎Mar 10, 2009‎
Nasal steroids like Flonase, Nasonex, Nasacort AQ, and Rhinocort Aqua help to treat seasonal allergies by reducing congestion and swelling. Retriever

GAZZETTA UFFICIALE: SOMMARIO (3)  -  ‎Mar 10, 2009‎
Autorizzazione all'immissione in commercio del medicinale per uso umano "Nasacort". Autorizzazione all'immissione in commercio del medicinale per uso umano ANSA Valle d'Aosta

10-Q: PERRIGO CO  -  Feb 3, 2009
In November 2008, the Company acknowledged the settlement of patent litigation relating to a generic to Nasacort(R) AQ (triamcinolone acetonide nasal spray) MarketWatch (press release)

Manhattan Research Releases Top Pharma Brand Product Sites by ...  -  Feb 3, 2009
Lantus, Lexapro, Levitra, Lipitor, Lunesta, Nasacort, Nasonex, Neulasta, Neurontin, Nexium, Norvasc, NuvaRing, Ortho Evra, Ortho Tri-Cyclen Lo, Paxil, PR Web (press release),

Don't let allergies come between you and your pets  -  Jan 17, 2009
For non-asthmatic symptoms (sneezing and watery eyes), pet lovers can use non-systemic medications such as Lanacort (a cream), Nasacort (an inhaler), Monitor,

Teva Grabs Billions Gambling on Copies of Brand Drugs (Update2)  -  Dec 1, 2008
...“I am sure the possibility Teva could launch at-risk on both Allegra-D and Nasacort played a part in Sanofi’s calculations,�? Gal said in an e-mail. Bloomberg

Examine the World Intranasal Drug Delivery Market  -  Dec 9, 2008
Studies for PMI-150 II-32 Nastech Commences Phase 2 Trials for Insulin Nasal Spray II-32 ACAAI Reveals Results for Trials of Nasacort(R) AQ Nasal Spray MarketWatch

Hypoallergenic hounds  -  Dec 14, 2008
Meadows said prescription nose sprays that contain cortisone, including Nasonex, Veramyst, Nasacort AQ, can be very effective. Montgomery Advertiser,

诺�?�与Mylan签署�??议解决Femara专利纠纷案  -  Dec 3, 2008
...普米克（�?�入布地奈德悬浮液）的仿制�?�。而赛诺�?�-安万特也已�?�巴尔�?�梯瓦解决了�?�两者侵犯其抗过�?�?�物Allegra（�?�索�?�那定）�?�Nasacort 慧�?�网,

Rhinite allergique : comment soigner cette réaction allergique  -  Dec 9, 2008
Il ya également les corticostéroïdes nasaux (Flonase, Nasacort, Nasonex) qui sont des médicaments anti-inflammatoires et qui peuvent remplacer les Web-Libre.org,

Business in the courts  -  23 Nov 2008
Sanofi sued Barr over the Nasacort nasal spray in 2006. The settlement halted a trial in Wilmington in which Sanofi accused Barr of infringing two patents The News Journal,

Sanofi settles some Allegra, Nasacort patent suits  -  Nov 19, 2008
Royalty rates under the Allegra D-12 and the Nasacort AQ licenses will take into account the number of AB-rated generics of these products on the US market, MarketWatch

FDA Safety Changes: Nasacort AQ, Reyataz, Zemuron  -  Nov 19, 2008
On September 19, the FDA approved safety labeling revisions for triamcinolone acetonide nasal spray (Nasacort AQ; sanofi-aventis US) to strengthen warnings Medscape (registration)

Sanofi-Aventis settles patent infringement lawsuits with Barr and Teva  -  Nov 21, 2008
Royalty rates under the Allegra D-12 and the Nasacort AQ licenses will take into account the number of AB-rated generics of these products on the US market. Pharmaceutical Business Review

Sanofi Breathing Easier  -  Nov 20, 2008
It'll be able to launch generic versions of extended-release Allegra in November of next year, and Nasacort AQ (in conjunction with partner Perrigo (Nasdaq: Motley Fool

Perrigo Acknowledges Settlement of NASACORT(R) AQ Nasal Spray ...  -  Nov 19, 2008
Barr believes that it is the first to file an Abbreviated New Drug Application (ANDA) containing a paragraph IV certification for NASACORT AQ. PR Newswire (press release),

BRIEF-Perrigo acknowledges settlement of Nasacort patent litigation  -  Nov 19, 2008
Interactive Investor Trading Limited, trading as "Interactive Investor", is authorised and regulated by the Financial Services Authority. Interactive Investor,

Business news in brief  -  Nov 20, 2008
...a patent lawsuit with Sanofi-Aventis over the allergy drugs Allegra and Nasacort, allowing sales of certain generic doses of the medicines early. Philadelphia Inquirer,

Sanofi ends patent dispute with Barr, Teva over allergy drugs  -  Nov 20, 2008
...patent litigation in the US against Barr Pharmaceuticals and Teva Pharmaceutical Industries over their copies of allergy medicines Nasacort and Allegra. SmartBrief,

Market Report -- In Play (PRGO)  -  Nov 19, 2008
Perrigo acknowledges settlement of NASACORT AQ nasal spray patent litigation The co acknowledges the settlement of patent litigation brought by MSN Money

Sanofi ends patent dispute with Barr, Teva over allergy drugs  -  Nov 20, 2008
...patent litigation in the US against Barr Pharmaceuticals and Teva Pharmaceutical Industries over their copies of allergy medicines Nasacort and Allegra. SmartBrief,

Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1):  -  Oct 31, 2008
2008 Announcement of FDA approval for Nasacort AQ(R) nasal spray in children aged 2 to 5 years September 25, 2008 Announcement that sanofi pasteur had PR Newswire (press release),

Sanofi-Aventis résout ses litiges brevetaires avec Teva et Barr  -  Nov 19, 2008
Le groupe pharmaceutique a indiqué qu'il accordait aux deux fabricants de génériques Teva et Barr une licence pour la commercialisation de Nasacort et Le Figaro,

AKTIEN NEW YORK/Ausblick: Verluste - Autobauer und Konjunktur ...  -  Nov 19, 2008
Barr Pharmaceuticals teilten mit, sie hätten einen Patentstreit mit Sanofi-Aventis über die Allergiemedikamente Allegra und Nasacort beigelegt. Swissinfo,

赛诺�?�安万特就专利侵�?�官�?�达�?和解  -  Nov 19, 2008
...赛诺�?�指控这两个竞争对手生产的其抗过�?�?�物Allegra与Nasacort 新浪网,

Sanofi-Aventis beendet Patentstreit mit Barr und Teva  -  Nov 19, 2008
Ferner wurde in 2006 eine Klage gegen Barr in Zusammenhang mit Nasacort eingereicht. Die Aktie von Sanofi-Aventis verliert aktuell in Paris 0,99 Prozent auf Stock World,

サノフィ�?アレルギー鼻炎薬�?�特許を�?ー�?�ライセンス  -  Nov 19, 2008
Nasacort AQ�?�関�?�るライセンス契約�?��?2011年6月�?�ら2013年12月�?�間�?�米国�?�後発薬�?�製造･販売を許�?��?�る。Allegra D-12 Hour�?��?��?��?��?��?2009年11月以�?�?�後発薬�?� IP NEXT ニュース,

赛诺�?�-安万特解决美国专利案�?许销售仿制�?�  -  Nov 20, 2008
...周三，世界第三大制�?�商法国赛诺�?�-安万特表示，其就仿制�?�商巴尔�?�梯瓦的低廉仿制�?��?侵犯其专利�?�所�??起的诉讼现已解决，其�?��?在抗过�?�?�物Allegra�?�Nasacort 慧�?�网,

賽諾�?�安�?�特就專利侵權官�?��?��?和解  -  Nov 19, 2008
...賽諾�?�指控這兩個競爭�?手生產的其抗�?��?藥物Allegra與Nasacort 新浪網,

Le Cac 40 se rapproche de son plus bas annuel  -  Nov 20, 2008
...un accord avec Barr Pharmaceuticals et Teva en vue de mettre fin aux poursuites concernant les brevets de l'Allegra et du Nasacort aux Etats-Unis. Les Échos,

AKTIEN NEW YORK/Schluss: Sehr schwach - Dow schliesst unter 8.000 ...  -  Nov 19, 2008
Barr Pharmaceuticals teilten mit, sie hätten einen Patentstreit mit Sanofi-Aventis über die Allergiemedikamente Allegra und Nasacort beigelegt. Swissinfo,

Les banques font à nouveau plier le marché  -  Nov 19, 2008
...un accord avec Barr Pharmaceuticals et Teva en vue de mettre fin aux poursuites concernant les brevets de l'Allegra et du Nasacort aux Etats-Unis. Les Échos,

Sanofi-Aventis: accords dans les litiges brevetaires aux USA  -  Nov 19, 2008
...(CercleFinance.com) - Sanofi-Aventis a signé deux accords transactionnels avec des fabricants de génériques portant sur Nasacort AQ et Allegra et Allegra Boursorama,

�?�입.비강스프레�?� 제네릭�? 기회  -  Nov 19, 2008
...�?�와 함께, 알레르기 비염 치료제 ‘나사코트’(Nasacort, triamcinolone)�?� 경우�?�?� 바 파마슈티컬스가 2011년부터 제네릭�?� �?매하기로 사노피아벤티스와 합�?�했으며, 디지틀보사,

Börsen in Europa: Deutliche Abschläge, Finanzwerte unter Druck  -  Nov 19, 2008
...heute bekannt gab, hat er den beiden Unternehmen den Verkauf ihrer generischen Versionen der Allergiemedikamente Allegra und Nasacort gestattet. AktienCheck,

RESULTATS DU TROISIEME TRIMESTRE 2008  -  Oct 31, 2008
Le conseil d'administration de Zentiva recommande le projet d'Offre Améliorée Annonce de l'homologation par la FDA de Nasacort AQ® spray 23 septembre 2008 Fininfo (Communiqué de presse),

Ragweed misery: How to find relief  -  Aug 20, 2008
Doctors can choose from several nasal sprays, including steroids, such as Nasacort and Flonase, and the antihistamine spray Astelin, Seiden said. Louisville Courier-Journal,

פריגו מסתערת על שוק של 10 מילי�?רד דולר  -  Sep 2, 2008
...לבל ציין שצבר המוצרי�? לטווח הקצר של החברה כולל �?ת הגרסה הגנרית לספריי Nasacort. פריגו הגישה �?ת הבקשה לשיווק המוצר יחד ע�? ב�?ר (ש�?מורה להירכש בידי חברת טבע) ה�?רץ,

Barr Pharmaceuticals, Inc. Q2 2008 Earnings Call Transcript  -  07 Aug 2008
We’ve had completed our trial in the NASACORT patent challenge in May… obtained full OTC status for Plan B in Canada. So across the board I think, Seeking Alpha,

Sanofi-aventis News  -  Jul 31, 2008
...+3.8% Nasacort(R) 60 -22.1% 130 -12.8% TOP 15 4027 +5.8% 8349 +3.7% Rest of the portfolio 2005 +0.8% 4072 -0.5% Total Pharmaceuticals 6032 +4.1% 12421 PR Newswire (press release),

Barr shares rise on Mirapex patent case victory  -  Jun 27, 2008
JPMorgan analyst Edmund C. Kim said the next major catalyst is a ruling on a patent challenge for Sanofi-Aventis SA's Nasacort AQ allergy spray, CNNMoney.com

Don't Let Allergies And Asthma Ruin Your Summer  -  Jun 5, 2008
Examples include fluticasone (Flonase/Flovent), budesonide (Rhinocort/Pulmicort), mometasone (Nasonex/Asmanex) and triamcinolone (Nasacort AQ/Azmacort). Boston Channel.com,

Barr shares rise on Bayer birth control pills deal  -  Jun 24, 2008
...restless legs syndrome drug Mirapex and allergy drugs Nasacort and Allegra D. Goldman Sachs' Randall Stanicky said the settlement is part of a theme in Forbes,

Omnaris: A New Nasal Steroid for Allergies  -  May 19, 2008
Flonase (fluticasone propinoate), Nasonex (mometasone), Veramyst (fluticasone furoate), Rhinocort (budesonide), Nasacort (triamcinolone) and others. About - News & Issues,

PROZAC ONLINE  -  May 12, 2008
Prozac but online cheap Nasacort online world where we have a choice. Help for depression. Acting on the NHS. This now is a selective serotonin re-uptake Rochester R News,

Action: Product comparison gives gas prices new perspective  -  May 30, 2008
Visine Eye Drops - $995.84 a gallon; Neutrogena Healthy Skin Makeup - $1162.47 a gallon; Krazy Glue - $2322.29 a gallon; Nasacort Nasal Spray - $2615.28 The Reporter,

FDA Approves Alcon’s Antiallergy Nasal Spray  -  Apr 22, 2008
They include Schering-Plough’s Nasonex (mometasone furoate monohydrate) and sanofi-aventis’ Nasacort AQ (triamcinolone acetonide). FDA news (subscription),

Collegium Pharmaceutical Announces FDA Filing for AllerNase™, a ...  -  Apr 8, 2008
Competing inhaled steroid products in this category include Nasonex® (Schering), Nasacort® (Aventis), Rhinocort Aqua® (AstraZeneca) and Veramyst® (Glaxo). Business Wire (press release),

Foods that form kidney stones  -  Feb 19, 2008
Its older cousins include Rhinocort, Nasalide, Nasacort, Nasonex and Flonase. These should be cheaper because they are older or they have a generic Ocala.com,

Sanofi-aventis Announces 2007 Earnings Ahead of Guidance Sharp ...  -  Feb 12, 2008
...+21.7% 15 +15.4% Nasacort(R) 10 +11.1% 50 -3.8% 7 0.0% Change Change Change on a on a on a FY 2007 comparable United comparable Other comparable (euro PR Newswire (press release),

Brand Names/Synonyms:
Nasacort is also known by the following brand names and/or synonymsAdcortyl; Aristocort; Aristocort A; Aristocort Tablets; Aristogel; Aristospan; Azmacort; CL 19823; Celeste; Cinolone; Cinolone-T; Delphicort; Fluoxiprednisolone; Fluoxyprednisolone; Flutex; HSDB 3194; Kenacort; Kenacort-A; Kenacort-Ag; Kenalog; Kenalog in Orabase; Kenalog-10; Kenalog-40; Kenalog-H; Ledercort; Nasacort; Nasacort Aq; Nasacort Hfa; Omcilon; Omicilon; Oracort; Oralone; Orion; Polcortolon; Rodinolone; Sk-Triamcinolone; Tiamcinolonum [Inn-Latin]; Tri-Nasal; Triacet; Triacort; Triam-Tablinen; Triamcet; Triamcinalone; Triamcinlon; Triamcinolon; Triamcinolona [Inn-Spanish]; Triamcinolone; Triamcinolone Acetonide; Triamcinolone Acetonide in Absorbase; Triamcinolone Diacetate; Triamcinolone [Usan:Ban:Inn:Jan]; Triamcinolonum [Inn]; Triatex; Tricortale; Triderm; Trymex; Vetalog; Volon

Drug Category:
Nasacort is categorized under the following by the FDA: Glucocorticoids; Anti-inflammatory Agents; Adrenergic Agents; ATC:A01AC01; ATC:D07AB09; ATC:D07XB02; ATC:H02AB08; ATC:R01AD11; ATC:R03BA06; ATC:S01BA05

Dosage Forms:
CREAM; LIQUID; METERED-DOSE (AEROSOL); OINTMENT; PASTE; SUSPENSION; SYRUP; TABLET

Absorption:
Rapid absorption following oral administration

Interactions:
Not Available

Chemical IUPAC Name:
9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one

:

Web health.mongabay.com/health

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com/health lead to other sites. health.mongabay.com/health does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com/health responsible for dead or misdirected links.

IF YOU NEED A LINK/TEXT REMOVED FROM THIS PAGE, PLEASE CONTACT: mongabay (at) gmail.com